Nectar Lifesciences (NECLIFE) Shareholding Pattern

NSE: NECLIFE • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 51.84%
FII Holding 0.58%
DII Holding 3.54%
Public Holding 35.83%
Total Shareholders 76,648
As of Jan 2026
View the latest shareholding pattern of Nectar Lifesciences (NECLIFE) including promoter, FII, DII, and public holdings. Track NECLIFE ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See NECLIFE yearly price range)

Nectar Lifesciences (NECLIFE) Shareholding Summary

  • Promoters have increased holding from 44.91% to 51.84% in Jan 2026
  • FII/FPI have increased holdings from 0.52% to 0.58% in Jan 2026
  • DIIs have decreased holdings from 5.82% to 3.54% in Jan 2026
  • Institutional investors have decreased holdings from 6.34% to 4.12% in Jan 2026
  • Public holding has decreased from 39.72% to 35.83% in Jan 2026
  • Number of shareholders decreased from 78,124 to 76,648 in Jan 2026

NECLIFE Quarterly Ownership Changes

Quarter-over-quarter changes for Nectar Lifesciences from Dec 2025 to Jan 2026.

Promoter Holding Change
Dec 2025 to Jan 2026
+6.93%
FII Holding Change
Dec 2025 to Jan 2026
+0.06%
DII Holding Change
Dec 2025 to Jan 2026
-2.28%
Public Holding Change
Dec 2025 to Jan 2026
-3.89%

Nectar Lifesciences (NECLIFE) Quarterly Shareholding Trends

Visual breakdown of NECLIFE ownership distribution over time. Learn more about NECLIFE fair price.

Promoter
FII
DII
Public
Government

Rising institutional holdings in NECLIFE often correlate with improved fundamentals. Check out NECLIFE Q4 results.

Nectar Lifesciences (NECLIFE) Shareholding Data

Download complete NECLIFE ownership data for offline analysis. Discover Nectar Lifesciences intrinsic price.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Jan 2026 51.84% 0.58% 3.54% 0.02% 35.83% 8.18% 99.99% 76,648
Dec 2025 44.91% 0.52% 5.82% 0.02% 39.72% 9.00% 99.99% 78,124
Sept 2025 44.91% 0.62% 0.09% 0.02% 44.70% 9.67% 100.01% 76,470
Jun 2025 44.53% 0.81% 0.19% 0.02% 44.12% 10.32% 99.99% 71,977
Mar 2025 44.53% 1.65% 0.16% 0.02% 41.60% 12.04% 100.00% 69,241
Dec 2024 44.53% 0.73% 0.00% 0.02% 39.36% 15.35% 99.99% 69,482
Sept 2024 55.80% 3.24% 0.00% 0.02% 30.45% 10.49% 100.00% 66,741
Jun 2024 55.80% 16.61% 0.00% 0.02% 23.69% 3.87% 99.99% 58,230
Mar 2024 55.80% 16.97% 0.00% 0.02% 23.32% 3.88% 99.99% 59,946
Dec 2023 55.80% 14.59% 0.00% 0.02% 24.34% 5.25% 100.00% 60,761
Sept 2023 55.80% 14.59% 0.00% 0.02% 24.45% 5.14% 100.00% 60,283
Jun 2023 55.80% 14.59% 0.00% 0.02% 24.61% 4.98% 100.00% 61,582
Mar 2023 55.80% 14.59% 0.00% 0.02% 24.46% 5.13% 100.00% 64,422
Dec 2022 55.80% 14.59% 0.00% 0.02% 24.52% 5.07% 100.00% 62,940
Sept 2022 55.80% 14.59% 0.00% 0.02% 24.33% 5.26% 100.00% 63,909
Jun 2022 55.80% 0.00% 0.00% 0.00% 24.20% 20.00% 100.00% 64,012
Mar 2022 55.80% 0.00% 0.00% 0.00% 23.82% 20.38% 100.00% 56,073
Dec 2021 55.80% 0.00% 0.00% 0.00% 23.60% 20.60% 100.00% 55,124
Sept 2021 55.80% 0.00% 0.00% 0.00% 22.53% 21.67% 100.00% 53,304
Jun 2021 55.80% 0.00% 0.00% 0.00% 21.99% 22.21% 100.00% 47,394
Mar 2021 55.80% 0.00% 0.00% 0.00% 22.43% 21.77% 100.00% 0

NECLIFE promoter holding above 50% indicates strong insider confidence. Explore the Nectar Lifesciences dividend policy for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Jan 2026 51.84% 0.58% 3.54% 0.02% 35.83% 8.18% 99.99% 76,648
Dec 2025 44.91% 0.52% 5.82% 0.02% 39.72% 9.00% 99.99% 78,124
Sept 2025 44.91% 0.62% 0.09% 0.02% 44.70% 9.67% 100.01% 76,470
Jun 2025 44.53% 0.81% 0.19% 0.02% 44.12% 10.32% 99.99% 71,977
Mar 2025 44.53% 1.65% 0.16% 0.02% 41.60% 12.04% 100.00% 69,241
Dec 2024 44.53% 0.73% 0.00% 0.02% 39.36% 15.35% 99.99% 69,482
Sept 2024 55.80% 3.24% 0.00% 0.02% 30.45% 10.49% 100.00% 66,741
Jun 2024 55.80% 16.61% 0.00% 0.02% 23.69% 3.87% 99.99% 58,230
Mar 2024 55.80% 16.97% 0.00% 0.02% 23.32% 3.88% 99.99% 59,946
Dec 2023 55.80% 14.59% 0.00% 0.02% 24.34% 5.25% 100.00% 60,761
Sept 2023 55.80% 14.59% 0.00% 0.02% 24.45% 5.14% 100.00% 60,283
Jun 2023 55.80% 14.59% 0.00% 0.02% 24.61% 4.98% 100.00% 61,582

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 44.91% 0.52% 5.82% 0.02% 39.72% 9.00% 99.99% 78,124
Dec 2024 44.53% 0.73% 0.00% 0.02% 39.36% 15.35% 99.99% 69,482
Dec 2023 55.80% 14.59% 0.00% 0.02% 24.34% 5.25% 100.00% 60,761
Dec 2022 55.80% 14.59% 0.00% 0.02% 24.52% 5.07% 100.00% 62,940
Dec 2021 55.80% 0.00% 0.00% 0.00% 23.60% 20.60% 100.00% 55,124

Year-over-year trends reveal long-term ownership shifts.

Understanding Nectar Lifesciences (NECLIFE) Shareholding Pattern

Nectar Lifesciences shareholding pattern reveals who owns NECLIFE stock and how ownership changes over time. High promoter stakes in NECLIFE often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your NECLIFE trades. NECLIFE book value comparison

Combine NECLIFE ownership analysis with price movements and financial performance for a complete investment picture. (See Nectar Lifesciences stock price data download)